Suppr超能文献

卵巢腺癌合并恶性心包积液并心脏压塞。

Malignant pericardial effusion with cardiac tamponade in ovarian adenocarcinoma.

机构信息

University of Iowa Carver College of Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, 52242, USA.

出版信息

Arch Gynecol Obstet. 2009 Oct;280(4):675-8. doi: 10.1007/s00404-009-0976-5. Epub 2009 Feb 19.

Abstract

BACKGROUND

Malignant pericardial effusion with cardiac tamponade is an uncommon metastatic manifestation of gynecologic cancers. We describe a patient with ovarian cancer who developed pericardial effusion with cardiac tamponade and was successfully treated with pericardiocentesis and intrapericardial instillation of thiotepa.

CASE

A 52-year-old woman with stage IV ovarian adenocarcinoma presented with worsening cough, dyspnea, and fatigue. Chest X-ray and echocardiogram confirmed the presence of pericardial effusion with cardiac tamponade. Pericardial fluid cytology revealed adenocarcinoma. Treatment consisted of pericardiocentesis with thiotepa sclerotherapy. She survived 12 months post-therapy without recurrent pericardial tamponade.

CONCLUSION

Patients with gynecologic cancers may develop a pericardial effusion with cardiac tamponade. Malignant pericardial effusion should be included in the differential diagnosis in patients with recurrent ovarian cancer who present with cardiac tamponade.

摘要

背景

恶性心包积液伴心脏压塞是妇科癌症少见的转移性表现。我们描述了一位卵巢癌患者,她发生心包积液伴心脏压塞,并成功地接受了心包穿刺和噻替派心包内灌注治疗。

病例

一位 52 岁女性患有 IV 期卵巢腺癌,表现为咳嗽加重、呼吸困难和乏力。胸部 X 线和超声心动图证实存在心包积液伴心脏压塞。心包积液细胞学检查显示为腺癌。治疗包括心包穿刺和噻替派硬化治疗。患者在治疗后 12 个月存活,无复发性心包压塞。

结论

妇科癌症患者可能发生心包积液伴心脏压塞。对于出现心脏压塞的复发性卵巢癌患者,应将恶性心包积液纳入鉴别诊断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验